Primary liver cancer, other malignancies, and mortality risks following porphyria: A cohort study in Denmark and Sweden

American Journal of Epidemiology

Volumn 149, Issue 11, 1999, Pages 1010-1015

  Linet, Martha S ^a   Gridley, Gloria ^a   Nyrén, Olof ^b   Mellemkjaer, Lene ^c   Olsen, Jorgen H ^c   Keehn, Shannon ^d   Adami, Hansolov ^b,e   Fraumeni Jr , Joseph F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Incidence; Liver cirrhosis; Liver neoplasms; Lung diseases, neoplasms; Mortality; Porphyria cutanea tarda; Porphyria, acute intermittent

Indexed keywords

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DENMARK; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; KIDNEY CANCER; LIVER CANCER; LIVER CIRRHOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; SWEDEN;

EID: 0033152845     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009745     Document Type: Article

References (45)

1. Batlle AM. Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B 1993;20:5-22.
2. Moore MR, McColl KE, Rimington C, et al. Disorders of porphyrin metabolism. New York, NY: Plenum Publishing, 1987:1-374.
3. Doss MO. Alcohol and porphyrin metabolism. In: Seitz HK, Kommerell B, eds. Alcohol-related diseases in gastroenterology. Berlin, Germany: Springer-Verlag, 1985:232-52.
4. Bengtsson NO, Hardell L. Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer 1986;54:115-17.
5. Lithner F, Wetterberg L. Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand 1984;215:271-4.
6. Kauppinen R, Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 1988;57:117-20.
7. Solis JA, Betancor P, Campos R, et al. Association of porphyria cutanea tarda and primary liver cancer: report of ten cases. J Dermatol 1982;9:131-7.
8. Salata H, Cortes JM, Enriques de Salamanca R, et al. Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors. J Hepatol 1985;1:477-87.
9. Thunnissen PLM, Meyer J, De Koning RW. Acute intermittent porphyria and primary liver cell carcinoma. Neth J Med 1991;38:171-4.
10. Hardell L, Bengtsson NO, Jonsson U, et al. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Br J Cancer 1984;50:389-97.
11. Mellemkjaer L, Olsen JH, Linet MS, et al. Cancer risk following splenectomy. Cancer 1995;75:577-83.
12. Nyrén O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1995;87:28-33.
13. Linet MS, Nyrén O, Gridley G, et al. Causes of death among patients surviving at least one year following splenectomy. Am J Surg 1996;172:320-3.
14. Bailar JC III, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964;20:639-43.
15. Kordac V. Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up. Neoplasma 1972;19:135-9.
16. Cortes JM, Oliva H, Paradinas FJ, et al. The pathology of the liver in porphyria cutanea tarda. Histopathology 1980;4:471-85.
17. Doss MO. Hepatic porphyrias: pathobiochemical, diagnostic, and therapeutic implications. In: Popper H, Schaffer F, eds. Progress in liver diseases. New York, NY: Grune and Stratton, 1982:573-97.
18. Lefkowitz JH, Grossman ME. Hepatic pathology in porphyria cutanea tarda. Liver 1983;3:19-29.
19. Campo E, Bruguera M, Rodes J. Are there diagnostic histologic features of porphyria cutanea tarda in liver biopsy specimens? Liver 1990;10:185-90.
20. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 1992;71:1-13.
21. Siersma PD, Ten Kate FJW, Mulder PGH, et al. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992;2:56-61.
22. Yu MC, Mack T, Hanisch R, et al. Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res 1983;43:6077-9.
23. LaVecchia C, Negri E, Decarli A, et al. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 1988; 42:872-6.
24. Adami HO, Hsing AW, McLaughlin JK, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 1992;51:898-902.
25. Herrero C, Vicente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-9.
26. Gumber SC, Chopra S, Hepatitis C: a multifaceted disease. Ann Intern Med 1995;123:15-20.
27. Pimstone NR. Hematologic and hepatic manifestations of the cutaneous porphyrias. Clin Dermatol 1985;3:83-102.
28. Meyer U. Porphyrias. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine. New York, NY: McGraw-Hill, 1991:1829-34.
29. Kappas A, Sassa S, Galbraith RA, et al. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The molecular and metabolic basis of inherited disease. 7th ed. New York, NY: McGraw-Hill, 1993:2103-59.
30. Roberts AG, Whatley SD, Morgan RR, et al. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-3.
31. Jackson H, Whatley SD, Morgan RR, et al. The haemochromatosis C282Y mutation in sporadic and familial porphyria cutanea tarda. (Abstract). Acta Haematol 1997;981:114.
32. Hsing AW, McLaughlin JK, Olsen JH, et al. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 1995;60:160-2.
33. Turnbull A, Baker H, Vernon-Roberts B. Iron metabolism in porphyria cutanea tarda and in erythropoietic protoporphyria. QJM 1973;42:341-55.
34. Adami HO, McLaughlin JK, Hsing AW, et al. Alcoholism and cancer risk: a population-based cohort. Cancer Causes Control 1992;3:419-25.
35. Stewart FP, Manson MM, Cabral JRP, et al. Hexachlorobenzene as a promoter of diethylnitrosamine-initiated hepatocarcinogenesis in rats and comparison with induction of porphyria. Carcinogenesis 1989;10:1225-30.
36. Van Birgelen APJM, Fase KM, van der Kolk J, et al. Synergistic effect of 2,2', 4,4', 5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic porphyrin levels in the rat. Environ Health Perspect 1996;104:550-7.
37. Gubler JG, Bargetze MJ, Meyer UA. Primary liver carcinoma in two sisters with acute intermittent porphyria. Am J Med 1990;89:540-1.
38. Kauppinen R, Mustajoki S, Pihlaja H, et al. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene. Hum Mol Genet 1995;4:215-22.
39. Bjersing L, Andersson C, Lithner F. Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations. Cancer Epidemiol Biomarkers Prev 1996;5:393-7.
40. Kozlowski LT, Ferrence RG. Statistical control in research on alcohol and tobacco: an example from research on alcohol and mortality. Br J Addict 1990;85:271-8.
41. Friedman GD, Tekawa I, Klatsky AL, et al. Alcohol drinking and cigarette smoking: an exploration of the association in middle-aged men and women. Drug Alcohol Depend 1991; 27:283-90.
42. Veenstra J, Schenkel JA, van Erp-Baart AM, et al. Alcohol consumption in relation to food intake and smoking habits in the Dutch National Food Consumption Survey. Eur J Clin Nutr 1993;47:482-9.
43. Statistics Sweden. Health in Sweden. Yearbook of health statistics, 1989. Stockholm, Sweden: Statistics Sweden, 1989.
44. Lambrecht RW, Sinclair PR, Gorman N, et al. Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450IA2. Arch Biochem Biophys 1992;294: 504-10.
45. Lip GY, McColl KE, Goldberg A, et al. Smoking and recurrent attacks of acute intermittent porphyria. BMJ 1991;302:507.